Join our growing community to challenge mainstream media bias and fix the news
AstraZeneca issues updated Phase 3 trial data of its Covid-19 vaccine

AstraZeneca issues updated Phase 3 trial data of its Covid-19 vaccine

AstraZeneca issued an updated data of its Phase 3 Covid-19 vaccine trial. This comes after the company came under heavy criticism over a preliminary report from its US study. In the updated data, the drugmaker said its vaccine is 76% effective in protecting against symptomatic Covid-19 cases and was ’well tolerated’ among trial volunteers. This is 3% less than what it said in a release on Monday.

Tom A
Tom A
John W
John W 4 weeks

Big pharma has been overly chritical because the cost is a few dollars vs $20 to $30 for the others. You could equally find small shifts in effectiveness in the other vaccines, but they ignore those of course. They also tried to say there were blood clots, when the amount sern was less than what was expected to happen in any population during the eame period of time. Ie certain percentage of people have bllod clots ever year regardless of any new medicine or vaccine they happen to have. They also compare effectiveness of vaccines that were tested before new variants and before variants. Obviously new variants are lowering effectiveness of all vaccines, over time.

World
World 4 weeks

The trust is already damaged bro...

Top in World